register

News - Pharmaceuticals

Pharmacy Guild supports real time monitoring of opioids

Health Industry Hub | February 10, 2020 |

The Pharmacy Guild of Australia welcomes the renewed push by Health Minister, Greg Hunt, to achieve a national system of real time opioid prescription monitoring by the end of 2020.

The Pharmacy Guild has long supported and called for the introduction of national real time recording of controlled drugs, a move which will benefit vulnerable patients and provide significant clinical decision-making support for doctors and pharmacists.

A national, uniform real-time monitoring system, will enable pharmacists to identify and support patients at risk of dependence and will also help to counter doctor shopping.

National President of the Pharmacy Guild of Australia, George Tambassis said: “We wholeheartedly welcome Minister Hunt’s declaration that real time recording across Australia is a matter of priority.

“Some States and Territories have already developed systems, but we need all jurisdictions on board and systems that talk to each other to ensure a nationally effective approach,” said Mr Tambassis.

“Victoria’s Safescript is evidence of the effectiveness of real time monitoring in reducing high-risk opioid doses. As a result of this program, high-risk opioid doses is reported to have decreased 25 per cent between April and October last year,” he said.

“Community pharmacists and the Guild stand ready to work with State and Territory Governments to make this a reality as soon as possible. We have to get this done,” Mr Tambassis said.

Enhance corporate branding and boost thought leadership to attract and retain quality employees. Health Industry Hub is the only one-stop-hub connecting Australia’s Pharma, MedTech, and Biotech industry professionals. Get started with our proven digital media solutions developed by industry for industry.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

You may also like New PBS listings to bring hope for Australians living with kidney disease, cystic fibrosis and cancer


News - MedTech & Diagnostics

PL reforms deliver $1 billion in savings but patients are yet to see the benefit

PL reforms deliver $1 billion in savings but patients are yet to see the benefit

Health Industry Hub | August 13, 2026 |

The final evaluation of the Prescribed List (PL) reforms has delivered a mixed verdict on one of the private health […]

More


News - Pharmaceuticals

Lilly global CEO takes aim at PBS over Mounjaro price fight - David Ricks

Lilly global CEO takes aim at PBS over Mounjaro price fight

Health Industry Hub | August 13, 2026 |

Eli Lilly’s global CEO has accused the Pharmaceutical Benefits Scheme (PBS) of failing to keep pace with a new era […]

More


News - Pharmaceuticals

Cheap old drug enters MS PBS review as access battle continues

Cheap old drug enters MS PBS review as access battle continues

Health Industry Hub | August 13, 2026 |

The Department of Health has outlined the scope and timelines of the Rapid review of PBS medicines for relapsing-remitting multiple […]

More


News - MedTech & Diagnostics

The piss test, missed diagnoses and the dialysis crunch: Kidney Action Week

The piss test, missed diagnoses and the dialysis crunch: Kidney Action Week

Health Industry Hub | August 13, 2026 |

Kidney Health Australia is taking an unconventional approach to a serious health issue, launching a national media campaign during Kidney […]

More


This content is copyright protected. Please subscribe to gain access.